0001213900-26-050131.txt : 20260430 0001213900-26-050131.hdr.sgml : 20260430 20260430153738 ACCESSION NUMBER: 0001213900-26-050131 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260128 FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ervin Jeffrey S CENTRAL INDEX KEY: 0001762163 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41160 FILM NUMBER: 26924349 MAIL ADDRESS: STREET 1: C/O IMAC HOLDINGS, INC. STREET 2: 1605 WESTGATE CIRCLE CITY: BRENTWOOD STATE: TN ZIP: 37027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 4 1 ownership.xml OWNERSHIP DOCUMENT X0609 4 2026-01-28 0 0001860657 Allarity Therapeutics, Inc. ALLR 0001762163 Ervin Jeffrey S false C/O ALLARITY THERAPEUTICS, INC. 123 E TARPON AVE TARPON SPRINGS FL 34689 0 1 0 0 CFO 0 Common Stock 2026-01-28 4 A 0 150000 0 A 150000 D The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date. /s/ Jeffrey S. Ervin 2026-04-30